Dr. Weiying Yuan
Dr. Weiying Yuan
Dr. Weiying Yuan is currently Site Head of Biostatistics and Clinical Informatics in Asia, Johnson and Johnson Pharmaceutical Research and Development (J&J PRD). She has been training and managing a group of biostatisticians and SAS programmers in Shanghai to provide biostatistical support to the J&J global clinical trial projects. She has gained broad experiences in global new drug development during her eighteen years working in the pharmaceutical companies. In her previous role as Senior Director, Clinical Biostatistics in Internal Medicine (IM), Weiying managed projects and staff members who were responsible for providing statistical support in the urologic, metabolism, and reproductive therapeutic areas in IM. Prior to IM, as a Global Statistical Leader, she led teams of biostatisticians and SAS programmers working on various successful worldwide filings and approvals of new drugs as well as new indications of marketed drugs in the antipsychotic and neurological product teams in the CNS area. Prior to J&J during her six years tenure at Merck, she had been a major contributor to the successful approval of Worldwide Medical Applications (WMAs) and New Drug Applications (NDAs) for new drugs on osteoporosis, analgesics, and arthritics.
Dr. Yuan is a member of ASA and DIA. She is also a permanent member of ICSA. She served as Treasurer of the ICSA Applied Symposium (2000-2002), Treasurer and Chair of the ICSA Financial Committee (2003-2005), and the Chair of the Biometrics Section of the ICSA (2008).
Dr. Yuan received her Ph.D. and M.S. degrees in Biostatistics at the University of Michigan and her B.A. in English Literature at Beijing Normal University. Her research interests include multivariate analysis, longitudinal and missing data analysis, and design and analysis of all phases of clinical trials. She has many professional publications in biostatistics and clinical trial applications and has given lectures at the Fudan and Jiaotong universities, Shanghai Clinical Research Center, DIA short courses, as well as to the CDE/SFDA staff.